The Defense Department has not released an exact accounting of the number of GLP-1 prescriptions written for weight loss, but a 2024 report noted that, by late 2023, the drugs made up roughly one-third of all prescription weight-loss medications for active-duty military personnel
Pharmacy benefit managers negotiate substantial rebates from manufacturers in exchange for preferred formulary status
and other factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time with the Securities and Exchange Commission
Your Ivm membership gives you access to sustained guidance and therapies focused on improving your metabolic well-being
We emphasize that lifestyle changes such as healthy eating and regular physical activity remain essential, and we incorporate these foundational strategies alongside any medical therapy
The appetite-suppressing effect of Semaglutide GLP-1 does not continuously increase over time
.png)
